Evidence map›Paper›PMID 34452049›Full record

ArticleVaccines2021

Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein.

Claudia Gandolfo, Shibily Prathyumn, Chiara Terrosi, Gabriele Anichini, Gianni Gori Savellini, Davide Corti, Luisa Bracci, Antonio Lanzavecchia, Gleyder Roman-Sosa, Maria Grazia Cusi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Humoral immunity to phlebovirus infection.Annals of the New York Academy of Sciences · 2023
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Claudia GandolfoVirology Unit, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Shibily PrathyumnVirology Unit, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Chiara TerrosiVirology Unit, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Gabriele AnichiniVirology Unit, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.ORCID 0000-0001-9895-2488
Gianni Gori SavelliniVirology Unit, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.ORCID 0000-0003-2287-9258
Davide CortiInstitute for Research in Biomedicine, 6501 Bellinzona, Switzerland.
Luisa BracciBiochemistry Unit, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Antonio LanzavecchiaInstitute for Research in Biomedicine, 6501 Bellinzona, Switzerland.
Gleyder Roman-SosaStructural Virology Unit, Virology Department, Institut Pasteur, 25-28 rue du Dr Roux, 75015 Paris, France.ORCID 0000-0003-1810-1347
Maria Grazia CusiVirology Unit, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.ORCID 0000-0001-8869-8164
University of Siena · ITInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging and re-emerging viral infections have been an important public health problem in recent years. We focused our attention on Toscana virus (TOSV), an emergent neurotropic negative-strand RNA virus of the

Indexed as

epitopeglycoproteinToscana virusvaccine

Identifiers

PMID34452049
PMCPMC8402642
OpenAlexW3195961297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.